Oct 082015
Talent4Boards - Great Talent builds Great Boards
– USA, CA – CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company developing therapies to treat metabolic diseases with high unmet medical need, today announced that Robert J. Wills, Ph.D., a member of the Board of Directors since March 2015, has been appointed Chairman of the Board of Directors.… => more
CymaBay Therapeutics names Robert Wills as Chairman of its Board of Directors
From:: CymaBay Therapeutics names Robert Wills as Chairman of its Board of Directors
Sorry, the comment form is closed at this time.